Neutropenia screening: Difference between revisions
Jump to navigation
Jump to search
m (Template) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ Neutropenia }} | {{ Neutropenia }} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{DG}} | ||
==Overview== | ==Overview== | ||
There are no routine screening recommendations for [[neutropenia]]. [[Neutropenia]] is typically identified incidentally on routine blood work or while monitoring after cytotoxic therapy. | |||
==References== | ==References== | ||
Revision as of 03:58, 7 November 2016
|
Neutropenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neutropenia screening On the Web |
|
American Roentgen Ray Society Images of Neutropenia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]
Overview
There are no routine screening recommendations for neutropenia. Neutropenia is typically identified incidentally on routine blood work or while monitoring after cytotoxic therapy.